Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05667519

Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)

Conditions: Tricuspid Regurgitation, Pacemaker Complication

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 324

Sponsor: LMU Klinikum

Location: Germany

Summary

This is the first randomized controlled trial comparing transesophageal echocardiography + fluoroscopy guided lead implantation vs. standard lead implantation guided by fluoroscopy only. Patients are randomized 1:1 in the two groups and followed up for up to 3 years.

Eligibility Criteria

Inclusion Criteria:indication for right ventricular lead implantation according to current guidelinesExclusion Criteria:preexisting tricuspid regurgitation ≥ grade 2other severe heart valve diseasehistory of tricuspid valve treatmentpreexisting right ventricular leadchronic dialysiscontraindication for transesophageal echocardiography

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05667519). StuddyBuddy aggregates publicly available trial information.